Gross Margin

Mark Reinbold takes the CEO role at CSC ServiceWorks, signaling a major strategic shift toward tech-driven, service-led models for the laundry giant.

Aspen Group reports a fourth straight profitable quarter through deep cost cuts, but its future growth hinges on a looming debt deadline and a major merger.

Jim Teske, the executive behind VRC's national expansion, is leaving. What does his departure mean for the company's aggressive acquisition strategy?

As MediciNova execs meet investors at the ROTH Conference, all eyes are on pivotal updates for its ALS, MS, and NAFLD drug candidates.

Israel's top value retailer posts stellar 2025 results, crediting supply chain mastery and rewarding shareholders despite regional challenges.

A DIY system promises water from thin air amid global uncertainty. We investigate if the Joseph's Well program is a real solution or just hot air.

Recon Technology's revenue doubles and losses shrink as overseas oilfield projects boom. The firm also pivots to a circular economy with a new recycling plant.

Aditxt's $36M acquisition of Ignite Proteomics aims to upend cancer therapy by analyzing protein activity, a high-stakes bet for the struggling innovator.

The German biotech firm secured its Nasdaq listing, but a near-total investor redemption leaves its cancer-drug pipeline with less than $1M in trust funds.

Crane NXT adds Benchmark Electronics CEO Jeffrey Benck to its board, signaling a strategic pivot towards deeper tech expertise as a veteran director departs.

The organic kids' food brand reports impressive sales and a strong IPO, but investors are keenly watching its strategy for long-term profitability.

Hydrafacial's parent company posts a massive jump in profitability for 2025, but slowing device sales and cautious guidance raise questions for 2026.

After a tough 2025, the gaming giant touts record margins and an aggressive 2026 plan, betting on new gear and a massive market catalyst for growth.

As FGI Industries prepares its 2025 results, investors watch for clues on the health of the home improvement sector amid economic uncertainty.

BRC Group Holdings announced a major debt reduction, but a history of late filings, shareholder dilution, and high-risk bets cast a shadow on its recovery.

A new report reveals a massive care gap for 76 million US cats, offering a $34 billion roadmap for vets to boost revenue and improve feline health.

New research shows a telehealth model boosting GLP-1 results to over 26% weight loss, but its reliance on unapproved compounded drugs raises safety flags.

A global industrial giant's 10-14% surcharge reveals the direct line from Mideast conflict to higher costs for your local hospital and restaurant.

The precision oncology firm reports a dramatic cut in net loss and a strategic pivot paying off, bolstered by a new U.S. patent for its cancer tech.

Blackline Safety posts record Q1 revenue, fueled by its booming recurring service model and new connected safety tech, despite a dip in US product sales.